Vancomycin AUC-Guided Initial Dose Calculator

Calculate vancomycin initial dosing to achieve target AUC24/MIC of 400–600 mg·h/L for MRSA infections using 2020 ASHP/IDSA/SIDP consensus guidelines and patient-specific pharmacokinetic parameters.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Calculate vancomycin initial dosing to achieve target AUC24/MIC of 400–600 mg·h/L for MRSA infections using 2020 ASHP/IDSA/SIDP consensus guidelines and patient-specific pharmacokinetic parameters

Each component has a specific meaning:

  • 2020 ASHP/IDSA/SIDP consensus guidelines — The 2020 ashp/idsa/sidp consensus guidelines recorded for the scenario being assessed.
  • Patient-specific pharmacokinetic parameters — The patient-specific pharmacokinetic parameters recorded for the scenario being assessed.

Note: Interpret the vancomycin auc dose result against the thresholds and context described above.

How to Use

Enter the 2020 ASHP/IDSA/SIDP consensus guidelines, patient-specific pharmacokinetic parameters for the scenario you are assessing. Calculate vancomycin initial dosing to achieve target AUC24/MIC of 400–600 mg·h/L for MRSA infections using 2020 ASHP/IDSA/SIDP consensus guidelines and patient-specific pharmacokinetic parameters. Use the vancomycin auc dose result to inform your calculation.

Frequently Asked Questions